79 related articles for article (PubMed ID: 10425458)
1. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding.
Qu X; Seale JP; Donnelly R
J Endocrinol; 1999 Aug; 162(2):207-14. PubMed ID: 10425458
[TBL] [Abstract][Full Text] [Related]
2. Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans.
Bergman BC; Hunerdosse DM; Kerege A; Playdon MC; Perreault L
Diabetologia; 2012 Apr; 55(4):1140-50. PubMed ID: 22252470
[TBL] [Abstract][Full Text] [Related]
3. Sensitive Fluorescent Biosensor Reveals Differential Subcellular Regulation of PKC.
Su Q; Zhang J; Lin W; Zhang JF; Newton AC; Mehta S; Yang J; Zhang J
bioRxiv; 2024 Mar; ():. PubMed ID: 38586003
[TBL] [Abstract][Full Text] [Related]
4. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
Itani SI; Zhou Q; Pories WJ; MacDonald KG; Dohm GL
Diabetes; 2000 Aug; 49(8):1353-8. PubMed ID: 10923637
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
Benabdelkamel H; Jaber MA; Dahabiyeh LA; Masood A; Almalki RH; Musambil M; Abdel Rahman AM; Alfadda AA
Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37343156
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis.
Bielawiec P; Dziemitko S; Konstantynowicz-Nowicka K; Chabowski A; Dzięcioł J; Harasim-Symbor E
Sci Rep; 2023 Mar; 13(1):3694. PubMed ID: 36879113
[TBL] [Abstract][Full Text] [Related]
7. Insulin Resistance: From Mechanisms to Therapeutic Strategies.
Lee SH; Park SY; Choi CS
Diabetes Metab J; 2022 Jan; 46(1):15-37. PubMed ID: 34965646
[TBL] [Abstract][Full Text] [Related]
8. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease.
Armandi A; Rosso C; Caviglia GP; Bugianesi E
Metabolites; 2021 Mar; 11(3):. PubMed ID: 33800465
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound
Abulizi A; Vatner DF; Ye Z; Wang Y; Camporez JP; Zhang D; Kahn M; Lyu K; Sirwi A; Cline GW; Hussain MM; Aspichueta P; Samuel VT; Shulman GI
J Lipid Res; 2020 Dec; 61(12):1565-1576. PubMed ID: 32907986
[TBL] [Abstract][Full Text] [Related]
10. Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications.
Gong M; Wen S; Nguyen T; Wang C; Jin J; Zhou L
Diabetes Metab Syndr Obes; 2020; 13():943-962. PubMed ID: 32280253
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease.
Akhtar DH; Iqbal U; Vazquez-Montesino LM; Dennis BB; Ahmed A
J Clin Transl Hepatol; 2019 Dec; 7(4):362-370. PubMed ID: 31915606
[TBL] [Abstract][Full Text] [Related]
12. Adipose glucocorticoid action influences whole-body metabolism
Abulizi A; Camporez JP; Jurczak MJ; Høyer KF; Zhang D; Cline GW; Samuel VT; Shulman GI; Vatner DF
FASEB J; 2019 Jul; 33(7):8174-8185. PubMed ID: 30922125
[TBL] [Abstract][Full Text] [Related]
13. Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice.
Abulizi A; Camporez JP; Zhang D; Samuel VT; Shulman GI; Vatner DF
Metabolism; 2019 Apr; 93():1-9. PubMed ID: 30576689
[TBL] [Abstract][Full Text] [Related]
14. Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis.
Tillander V; Miniami A; Alves-Bezerra M; Coleman RA; Cohen DE
J Biol Chem; 2019 Feb; 294(6):2009-2020. PubMed ID: 30523156
[TBL] [Abstract][Full Text] [Related]
15. The PI3K/AKT pathway in obesity and type 2 diabetes.
Huang X; Liu G; Guo J; Su Z
Int J Biol Sci; 2018; 14(11):1483-1496. PubMed ID: 30263000
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Insulin Action and Insulin Resistance.
Petersen MC; Shulman GI
Physiol Rev; 2018 Oct; 98(4):2133-2223. PubMed ID: 30067154
[TBL] [Abstract][Full Text] [Related]
17. Dietary Flavonoids in the Prevention of T2D: An Overview.
Alkhalidy H; Wang Y; Liu D
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29614722
[TBL] [Abstract][Full Text] [Related]
18. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
Samuel VT; Shulman GI
Cell Metab; 2018 Jan; 27(1):22-41. PubMed ID: 28867301
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
Ballestri S; Nascimbeni F; Romagnoli D; Baldelli E; Targher G; Lonardo A
Int J Mol Sci; 2016 Mar; 17(3):355. PubMed ID: 27005620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
